Kansas City

Integrated Kidney Partners XXIII LLC

Primary Contact

 

Ryan Pardo
Ryan.Pardo@usrenalcare.com

 

KCE Participants

 

Practices

 

KANSAS CITY KIDNEY CONSULTANTS PA

AHMED AWAD RACHEL LUBER
BARRY WOOD KYRSTIN ALEXANDER
EMILY JOHNSTON RYAN LUSTIG
GRETCHEN CASPER ASHLEY ARROWOOD
IRME AKHTAR BRANDON CALHOUN
MOLLY CAHILL SUZANNE CUMMINGS

NEPHROLOGY ASSOCIATES MD PA

ACHAL DESAI ROBERTA MOTT
ANNE SPADE ARCHANA GOEL
CATHERINE MOSS CONNIE ROE
VENU NAIR HEATHER CONKLIN
JAMES REDINGTON JUSTIN TEIWES
KAMAL HATAHET KRISTINE HERRON
MAGDALENA GLUCH MICHAEL LAMBERT
NAJINDRA MAHARJAN RICHARD SCHUMACHER
SUGANTHI BEEKI SULEIMAN DAIFALLAH
TESSA WEIGEL

KIDNEY ASSOCIATES OF KANSAS CITY PC

AHMED AL-ABSI AMBER MCGEE
GLORY CHUKWUSOM KARID NIEVES-BORRERO
MOHAMMED MOHIALDEEN NICOLE ROMINE
PRANAVKUMAR DALAL RICHARD MUTHER
WILLIAM PETERSON KELLY ALFORD

WICHITA NEPHROLOGY GROUP, PA

AMANDA VALLIANT EDGARD WEHBE
ERICA ROACH JANY MOUSSA
JOSEPH MEOUCHY LEVI SHORT
MICHAEL GRANT MOHAMAD SANDID
RONNIE MOUSSA SHAWNA ABENDROTH
TRACY SMITH USHASRI CHALLA
WISSAM SALIBA

 

MOGILISHETTY PLLC 

GAUTHAM MOGILISHETTY

 

Preferred Providers

Practice Provider Name
TRANSTREME LLC RICK MICHEL
CARE CONNECTORS MEDICAL GROUP INC  
EASY HEALTH MEDICAL SOLUTIONS P.C.  
HEART CENTERED COUNSELING PC  
PSYCHOLOGICAL & BEHAVIORAL CONSULTANTS INC  
ADVENT MEDICAL GROUP LLC  
PSYCHIATRIC COUNSELING ASSOCIATES LLC  

 

Joint Ventures

 

There are no joint ventures between or among the KCE and any of its KCE Participant and Preferred Providers.

Administrative Lead

Name Employer
ALAN ST. PIERRE KIDNEYLINK

 

Clinical Lead

Name Employer
DR. RYAN LUSTIG KANSAS CITY KIDNEY CONSULTANTS

 

KCE Governing Body Members

Name Employer
Ryan Lustig KANSAS CITY KIDNEY CONSULTANTS PA
Gautham Mogilishetty Mogilishetty PLLC
Richard Shumacher NEPHROLOGY ASSOCIATES MD PA
Thao Pascual U.S. Renal Care
Alan St. Pierre Kidneylink
Carol Ecklund Kidneylink
Melinda Myers Kidneylink
Lori Hartwell Renal Support Group

 

Shared Savings and Shared Losses Information, Including

 

a. Amount of Shared Savings or Shared Losses:

PY2023 Shared Savings will be reported in early 2025.

 

b. Proportion of Shared Savings invested in infrastructure, redesigned care processes, and other resources necessary to improve outcomes and reduce Medicare costs for Beneficiaries:

PY2023 Shared Savings will be reported in early 2025.

 

c. Proportion of Shared Savings distributed to KCE Participants and Preferred Providers:

PY2023 Shared Savings will be reported in early 2025.

 

Quality Measure Performance

 

Quality Measure Performance for PY2023 will be reported in early 2025.